Summary. Bifunctional recombinant plasmids were constructed, comprised of the E. coli vectors pBR322, pBR325 and pACYC184 and different plasmids from Gram-positive bacteria, e.g. pBSU161-1 of B. subtilis and pUBll0 and pC221 of S. aureus. The beta-lactamase (bla) gene and the chloramphenicol acetyltransferase (cat) gene from the E. coti plasmids were not transcribed and therefore not expressed in B. subtilis. However, tetracycline resistance from the E. coli plasmids was expressed in B. subtilis. Transcription of the tetracycline resistance gene(s) started in B. subtilis at or near the original E. eoti promoter, the sequence of which is almost identical with the sequence recognized by a 55 of B. subtilis RNA polymerase.
Introduction
The Gram-positive soil bacterium Bacillus subtilis is considered harmless for man and animals and is widely used in basic and applied microbiology. Efforts have been made to apply the techniques of molecular cloning, which are highly developed for the Gram-negative enterobacterium Escherichia coli, to B. subtilis (Ehrlich 1978; Goebel et al. 1979; Lovett and Keggins 1979; Dubnau et al. 1980 ) and several plasmid vector systems have been reported. These involve plasmids capable of replication in B. subtilis alone or in B. subtiIis and other Gram-positive microorganisms (Ehrlich 1977; Gryczan etal. 1978; Wilson and Baldwin 1978; Bernhard etal. 1978; Ehrlich et al. 1982) or alternatively bifunctional plasmids able to replicate in both E. coli and B. subtilis (Ehrlich 1978 ; Kreft et al. 1978; Kreft and Hughes 1982) . In this paper we describe the construction of bifunctional plasmids which allow studies on the expression in B. subtilis of three antibiotic resistance genes from E. coli.
Materials and Methods
Bacterial Strains. E. coli 5K, r-, m-was obtained from S. Glover, and JC1569 recA, thy-, arg-, his-, met-, leu , am r harbouring pACYC184 from S. Cohen. B. subtilis BR151CM1 trpC2, metBlO, lys3, spoCM1 was kindly provided by P. Lovett.
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Source of Reagents. All reagents if not otherwise stated were obtained from Merck, FRG. The antibiotics used were a gift from Bayer, FRG. Sodium dodecyl sulfate (SDS), ethidium bromide, polyethylene glycol type 6000, lysozyme and pancreatic RNase were purchased from Serva, FRG.
Enzymes. The restriction enzymes EcoRI, BamHI, HindIII, SalI, PstI, XbaI and T4 DNA ligase were obtained from BRL (USA) or Biolabs (USA). $1 nuclease was purchased from BRL.
Growth of Strains, Cell Lysis and Purification of Plasmid
DNA were performed as previously described (Mayer et al. 1977; Bernhard et al. 1978) .
Cleavage of DNA and EIectrophoresis in Agarose Gels. Digestion with restriction enzymes were carried out as indicated by the manufacturers. The reactions were stopped by heating the reaction mixture to 68°C for 8 rain or by addition of EDTA (100 mM final conc.). Electrophoresis was carried out in 1% agarose slab gels in 36 mM Tris-HC1, 30 mM NaHzPO 4, 10 mM EDTA, pH 7.5 (Meyers et al. 1975) .
Construction of Hybrid Plasmids and Transformation.
The in vitro construction of hybrid plasmids (Cohen et al. 1973) using T4DNA ligase, transformation of E. coli and of B. subtilis protoplasts have been described (Goebel and Bonewald 1975; Kreft et al. 1978; Chang and Cohen 1979) .
Purification of RNA. Isolation of RNA from B. subtilis BR151 was performed according to Glisin et al. (1974) by cell lysis with sarkosyl (4% w/v) and subsequent centrifugation through a cushion of CsC1 (p=1.71 g/cm) in 0.1 M EDTA pH 8.0. The RNA from the pellet was treated with DNAseI (Worthington) in the presence of ribonuclease inhibitor (vanadyl-ribonucleoside complex, BRL) to remove traces of contaminating DNA.
DNA/RNA Hybridization. The dot-blot method was used according to Kafatos et al. (1979) using 25-100 gg of RNA per dot and gene specific DNA probes labeled by nicktranslation (0.5-1.0x 10 6 cpm/gg) with ~-32P-dNTPs according to de la Cruz et al. (1980) .
S1
Nuclease Mapping. Transcripts were analyzed by the method of Berk and Sharp (1977) . The experiments were (Kreft et al. 1978) . The construction of pJKK20t is described in the text. Fragment sizes are given in kilobase-pairs (kb) performed with total RNA from B. subtilis BR151 carrying the plasmid under study. The RNA was purified as described above. After ethanol precipitation the RNA was dissolved in 30 gl hybridization buffer (Berk and Sharp 1977) to a concentration of 6.6 mg/ml. Fifteen pl of RNA (100 pg) were mixed with 5 ~tl of 32P-end-labeled DNA fragment (0.5 gg DNA, 5 x 105 cpm/gg). After 15 rain at 70 ° C hybridization was carried out at 53 ° C for 4 h. The mixture was then cooled in ice, diluted 10-fold with S1 nuclease buffer and 37.5 units of $1 nuclease (BRL) were added. After 30 rain at 37 ° C the hybrids were precipitated by ethanol and either applied directly to DNA sequencing gels (6% polyacrylamide, 31% urea) or denatured in alkali (Green and Roeder 1980) prior to electrophoresis.
Elution of DNA Fragments. Restriction fragments of plasmid DNA were eluted from agarose gels by electroelution in dialysis bags using 10 mM Tris-acetate buffer pH 8.0 in the elution chamber (4 mA/cm, 45 rain).
DNA Sequencing. Restriction fragments from plasmid DNA were cloned into M13mp8 according to Messing and Vieira (1982) . Single-stranded recombinant DNA was isolated from phage and the nucleotide sequence of the inserted DNA was determined by the chain-termination 385 method (Sanger et al. 1977 ) using a synthetic oligonucleotide as primer (gift of P.H. Seeburg, Genentech).
Results

Expression of Ampicillin Resistance
As previously reported, hybrid plasmids consisting of the E. coli vector pBR322 (Bolivar et al. 1977) and different parts of the B. subtilis plasmid pBSU161 have been constructed in vitro (Kreft et al. 1978) . Plasmid pJKK3 (Fig. 1) . In order to localize the block in the expression of the beta-lactamase (bla) gene in B. subtilis we investigated next the in vivo transcription of this gene in B. subtilis. For this, RNA was purified from B. subtilis BR151 containing pJKK3 and dot blot hybridization (Kafatos et al. 1979 ) was carried out using the 3ep-labeled small EcoRI/PstI fragment ofpBR322, which contains most of the bla gene, as a gene specific probe. Figure 2 shows that no hybridization was obtained, indicating that the bla gene originating from pBR322 is not transcribed in B. subtilis. Deletions which may occur in pJKK3 during or subsequent to transformation into B. subtilis were not responsible for the lack of expression of the bla gene since this gene was fully functional upon retransformation of E. coli with plasmid DNA isolated from B. subtilis.
Expression of Chloramphenicol Resistance
A recombinant plasmid Constructed in vitro from the E. coli vector pACYC184 (Chang and Cohen 1978) and pBSU161-1 (Kreft etal. 1978) , lead in E. coIi to the formation of pJKK201 (Fig. 1 ). The plasmid was apparently generated in vivo by an extensive deletion of the primary ligation product and expressed tetracycline and chloramphenicol resistance in E. coli (Kreft et al. 1978 . B. subtilis could be transformed with pJKK201 to tetracycline resistance but not to chloramphenicol resistance. Plasmid DNA isolated from B. subtilis BRI51 transformed with pJKK201 could retransform E. coli to chloramphenicol resistance. This indicates that the gene for chloramphenicol acetyltransferase (cat) is maintained in B. subtilis without rendering these cells resistant to chloramphenicol. Restriction analysis of the plasmid DNA isolated from B. subtilis transformed with pJKK201 also showed that the cat gene was structurally intact even in derivatives of pJKK201 which have been deleted in vivo in B. subtilis (results not shown). RNA was isolated from B. subtilis BR151 containing pJKK201 and dot blot hybridization was carried out using the 32p-labeled small HindIII/PstI fragment of pBR325 (Bolivar 1978 ) as a probe-specific for Tn9-related cat genes. Figure 2 shows that no hybridization was obtained. This demonstrates that the cat gene from pACYC184 was also not transcribed in B. subtilis. 
Expression of Tetracycline Resistance
It has been previously shown that the tetracycline resistance encoded by the Bacillus plasmid pBSU161-1 was expressed in E. coIi (Kreft et al. 1978) . We have also shown that a bifunctional plasmid consisting of the cryptic B. subtilis plasmid pBSU1 and the E. coli vector pBR322 (Bolivar et al. 1977 ) could transform B. subtilis to tetracycline resistance (Goebel et al. 1979) . In order to investigate further the expression of this E. coli derived tetracycline resistance determinant in B. subtilis two other recombinant plasmids were constructed in vitro.
pJKK310 consists of pBR325 (Bolivar 1978 ) and pUBII0 linearized by EcoRI and ligated subsequently with T4 DNA ligase (Fig. 3) . This plasmid expressed resistance to ampicillin, kanaycin and tetracycline in E. coli. pJKK523 was constructed by ligating EcoRI linearized pBR322 with the staphyloccocal chloramphenicol resistance plasmid pC221 (Ehrlich 1977 ) which was also linearized by EcoRI (Fig. 3) . After transformation of E. coli with the ligation mixture, colonies were selected which were resistant to ampicillin, chloramphenicol and tetracycline. B. subtilis protoplasts could be transformed by pJKK310 to kanamycin resistance or tetracycline resistance using DM3 regeneration plates (Chang and Cohen 1979) containing 100 gg/ml kanamycin or 15 gg/ml tetracycline, respectively, pJKK523 could transform B. subtilis to chloramphenicol resistance or tetracycline resistance using 7.5 gg/ml chloramphenicol or 15 gg/ml tetracycline in the selective regeneration medium. Most of the transformants obtained on single-selective agar plates did not express the second resistance marker present on the parental plasmid isolated from E. coli. Attempts to obtain transformants with these plasmids on double-selective regeneration plates failed. All of the single-resistant transformants contained plasmids which had suffered large deletions. Tetracycline resistant clones of B. subtilis obtained after transformation with pJKK523 harbored a deleted plasmid which contained most of the pBR322 sequence; their chloramphenicol resistant counterparts also contained a plasmid smaller than pJKK523 (results not shown). After subcultivation of the chloramphenicol resistant transformants no plasmid DNA could be isolated from these still chloramphenicol resistant strains, suggesting that the plasmid or part of it had become integrated into the chromosome. This shows that both Only a few percent of the transformants obtained with these plasmids expressed both resistance markers, i.e. kanamycin plus tetracycline resistance or chloramphenicol plus tetracycline resistance in B. subtilis. All these transformants contained plasmid DNA which was indistinguishable from the parental plasmids by restriction analysis (data not shown).
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These results indicate that the tetracycline resistance gene (tet) of pBR322 or pBR325 was expressed in B. subtilis in contrast to the two other antibiotic resistance genes mentioned above.
Next, we determined if the transcription of this tet gene starts in B. subtilis at its original (E. coli) promoter in these hybrid replicons or whether transcription of the tetracycline resistance gene is mediated by a read-through transcript starting at a promoter in the S. aureus par; of the recombinant plasmids. In pJKK310 the tet gene is about 1,000 bp away from the junction site between the two parental plasraids; in pJKK523 this distance is only 30 bp.
By S1 nuclease mapping (Berk and Sharp 1977) we analyzed the transcripts from the E. coil tet gene which were synthesized in B. subtilis BR151 carrying intact pJKK310 or pJKK523, respectively. Total RNA was isolated from these strains and hybridized to suitable restriction fragments of the plasmids which were end-labeled with 32p. In the case of pJKK310 the plasmid was cut by BamHI, labeled with 32P-y-ATP and T4 polynucleotide kinase and b,P, The fragments were separated by electrophoresis on agarose gels. The BamHI/EcoRI fragment upstream from the BarnHI site in the tetracycline resistance gene was isolated from the gel and used as a hybridization probe. The transcription from pJKK523 was analyzed by using the BamHI/XbaI fragment containing the presumed start site of the tet gene for the hybridization. Treatment of the DNA/RNA-hybrids with $1 nuclease and subsequent separation on denaturing polyacrylamide/urea gels showed (Fig. 4) that the longest transcript obtained in vivo with both plasmids had a size of about 330 bases. This size is very close to the expected size for a transcript starting at the original promoter of the E. coli tetracycline resistance determinant (tet promoter).
To obtain further evidence that the original E. coli tet promoter functions in B. subtilis, a derivative of pJKK310 was constructed, pJKK310 was linearized with HindIII which cuts within the -10 region of the tet promoter. The sticky ends were filled in using AMV reverse transcriptase (James et al. 1982 ) and blunt-end ligated by TE4 DNA ligase. E. coli was transformed with the ligation mixture, kanamycin resistant and tetracycline sensitive transformants were selected. One of these contained a plasmid, designated pJKK310 AHind, which was identical to pJKK310 except that the HindIII site which is located in the tet promoter was destroyed by insertion of four base pairs, thus changing the distance between the -35 and -10 regions of the tet promoter. It has been previously demonstrated that slight changes in this distance strongly affect the promoter activity in E. coli (Russel and Bennett 1982) . B. subtilis protoplasts could be transformed by pJKK310 AHind to kanamycin resistance, transformation to tetracycline resistance failed. In this case all the kanamycin resistant and tetracycline sensitive transformants contained a plasmid indistinguishable from pJKK310 AHind (data not shown). This clearly indicates that inactivation of the E. coli tet promoter also prevented the expression of the tetracycline resistance in B. subtilis and further suggests that the tet gene from pBR325 (which is identical to that of pBR322) was transcribed from its own promoter in B. subtilis. The possibility that a frame-shift caused by the four base pair insertion at the original HindIII site resulted in the formation of an altered and inactive fusion protein transcribed and translated from the S. aureus part of pJKK310 can be ruled out since there are several translation-stop codons in the pBR325 sequence preceeding the tet promoter (positions 12, 29, 36, 44, 58, 66 in pBR322) in all three reading frames. To see if any mutation(s) occured in the tet promoter region of pJKK310 after transformation of the plasmid into B. subtilis this region was sequenced and compared to the published sequence of pBR325 (Prentki et al. 1981) . The nucleotide sequence of the tet promoter region of pJKK310 was found to be identical with that of pBR325 (Fig. 5 ).
Discussion
The three E. coli genes investigated in this study which express resistance to ampicillin (bla), chloramphenicol (cat) and tetracycline (tet) are well characterized. The sequence of the structural genes and their transcription control regions in E. coli was determined (Sutcliffe 1979; Alton and Vapnek 1979) . In addition the promoters and the initiation points of the in vitro transcripts have been mapped (Le Grice and Matzura 1981 ; Russel and Bennett 1981 ; Stfiber and Bujard 1981) . The transcriptional mechanism of B. subtilis is more complex than that of E. coli (Losick and Pero 1981) . The similarity between E. coli promoters and B. subtilis vegetative promoters (Lee and Pero 1981 ; Losick and Pero 1981 ; Moran et al. 1982) If one compares the consensus sequences in the -35 and -10 regions (TTGACA and TATAAT, respectively) of B. subtilis vegetative promoters (Losick and Pero 1981) which are recognized by the initiation factor a 5s, with the corresponding sequences of the E. coli bla, eat and tet promoters one observes a striking homology between the B. subtilis and the E. coli tet promoters with only one mismatch in the -10 region (Fig. 5) . On the other hand the promoter sequence for the bla gene shows two mismatches in both the -35 and -10 regions with three purine/pyrimidine nucleotide substitutions. The cat promoter has hardly any homology in the -35 region, the sequence with maximum homology having four mismatches with three purine/ pyrimidine nucleotide substitutions; the -10 region has one mismatch, in addition the distance between the -35 and -10 regions is 20 base pairs instead of the 17 base pairs found with the other promoters (Fig. 5) .
The B. subtilis phage SPO1 early genes SPO1-15 and SPO1-26 show conserved oligo-(dA) and oligo-(dT) sequences upstream from the -35 region (Lee and Pero 1981) (Fig. 5) . It has been quoted that such sequences may be essential for B. subtilis vegetative promoters (Murray and Rabinowitz 1982; S. Chang, 4th International Symposium on Genetics of Industrial Microorganisms, Kyoto 1982). However, neither the E. coli tet promoter nor the promoters of the 29 k leader peptide from pE194 (Horinouchi and Weisblum 1980; Gryczan et al. 1980 ) which initiates transcription of the erythromycin resistance gene, and of the pC194 eat gene (Horinouchi and Weisblum 1982) show such sequences (Fig. 5) . Nevertheless all three genes, which only show homology in their -35 and -10 regions, are readily expressed in B. subtilis (Ehrlich 1977; Weisblum et al. 1979) .
Therefore it seems likely that the degree of homology in the -35 and -10 promoter regions of heterolous genes with the consensus sequence for B. subtilis vegetative (a55) promoters is essential for the expression in vegetative B. subtilis cells. Additional sequence homologies in other parts of the promoter region may well have an influence on the promoter efficiency in this bacterium, in which, apparently, more stringent sequence requirements have to be met by promoters than in E. coli.
